Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma
Naoe Goto, Hisashi Tsurumi, Masao Takemura, Takeshi Hara, Michio Sawada, Senji Kasahara, Nobuhiro Kanemura, Toshiki Yamada, Masahito Shimizu, Takeshi Takahashi, Eiichi Tomita, Mitsuru Seishima, TsuyosVolume:
77
Year:
2006
Language:
english
Pages:
9
DOI:
10.1111/j.1600-0609.2006.00702.x
File:
PDF, 606 KB
english, 2006